The World Health Organization (WHO) has officially certified Denmark for the elimination of mother-to-child transmission (EMTCT) of HIV and syphilis, a landmark achievement that underscores the country’s long-term commitment to maternal and neonatal health. By securing this validation, Denmark becomes the first member of the European Union to reach this public health milestone, setting a rigorous standard for other high-income nations to follow. The certification recognizes that Denmark has established a healthcare infrastructure capable of ensuring that every child is born free of these life-altering infections, achieved through a combination of universal health coverage, systematic screening, and a human-rights-based approach to clinical care.
This recognition follows an exhaustive evaluation process conducted throughout 2025. The validation was based on an assessment by the WHO Regional Validation Committee in June 2025, followed by a final review by the Global Validation Advisory Committee (GVAC) in August 2025. The committees confirmed that Denmark successfully met and maintained all required global targets between 2021 and 2024. These criteria include not only low transmission rates but also high coverage of prenatal testing and immediate access to treatment for pregnant women.
A Decades-Long Journey to Public Health Excellence
The elimination of mother-to-child transmission is not an overnight success but the culmination of decades of integrated public health strategies. Since the late 20th century, Denmark has prioritized maternal health through its universal healthcare system, which provides equal access to services regardless of a patient’s socioeconomic status. This foundation has allowed the Danish Health Authority to implement comprehensive screening programs that capture nearly 100% of the pregnant population.
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, highlighted the significance of the achievement, noting that the elimination of mother-to-child transmission of HIV and syphilis marks a major public health victory. He emphasized that this milestone proves that with strong political commitment and consistent investment in primary care and integrated maternal and child health services, countries can protect every pregnant woman and newborn from these diseases. The Director-General’s remarks point to a broader global truth: the tools to end these transmissions exist, and Denmark’s success serves as a blueprint for their effective application.
Strict Benchmarks and Statistical Success
The WHO’s validation process is notoriously rigorous, requiring countries to provide verifiable data that they have met specific impact and process targets. To achieve EMTCT status, a country must demonstrate that it has tested and treated at least 95% of all pregnant women for both HIV and syphilis. Furthermore, the rate of new infant infections must be kept below 50 per 100,000 live births consistently over several years.
Denmark’s data systems, cited by the WHO as exemplary, provided the evidence needed for this certification. In the realm of HIV, Denmark reports approximately 5,950 people living with the virus nationwide. Among pregnant women, the prevalence is exceptionally low, affecting less than 0.1% of the population. Through routine testing and the immediate administration of antiretroviral therapy (ART) to expectant mothers living with HIV, Denmark has effectively reduced the transmission rate to infants to zero.
The success in syphilis elimination is equally noteworthy. Congenital syphilis—syphilis passed from mother to baby—can lead to severe complications, including stillbirth, neonatal death, and long-term disabilities. Denmark’s systematic prenatal screening and rapid treatment protocols have made the condition uncommon. In 2024, the country reported 626 cases of syphilis overall, with a significant gender disparity: 524 cases were reported in men and 102 in women. By identifying these cases early in pregnancy, the Danish healthcare system prevents the bacteria from crossing the placenta, ensuring the safety of the newborn.
The Role of Universal Healthcare and Human Rights
At the heart of Denmark’s success is a healthcare model built on the principle of equal access. Sophie Løhde, Denmark’s Minister for the Interior and Health, expressed pride in the validation, attributing the success to the tireless work of healthcare professionals, midwives, and public health teams. She noted that the universal health system has been the foundation of this achievement, ensuring that every pregnant woman, regardless of her background, receives the screening and care she needs.
The WHO also praised Denmark for its respect for women’s rights. The Danish approach emphasizes voluntary testing and informed consent, avoiding the coercive measures that can sometimes drive vulnerable populations away from healthcare services. By fostering a high-trust environment where patient privacy and dignity are respected, Denmark has ensured that even marginalized groups, such as migrants or those in precarious social situations, feel safe accessing prenatal care.
Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, remarked on the regional importance of this event. He stated that as the first European Union country to achieve this milestone, Denmark’s success is a testament to the strength of its maternal health system. He further noted that elimination means maintaining these benchmarks year after year through reliable data systems and robust antenatal care.
Moving Toward Triple Elimination: The Hepatitis B Challenge
While the current certification covers HIV and syphilis, the Danish government and the WHO are already looking toward the next goal: "triple elimination." This term refers to the simultaneous elimination of mother-to-child transmission of HIV, syphilis, and the hepatitis B virus (HBV).
Denmark is currently on track to validate the elimination of HBV. The prevalence of chronic hepatitis B infection in Denmark is estimated to be between 0.2% and 0.3%. Public health data indicates that these cases are primarily found among migrants from regions where the virus is endemic. To tackle this, Denmark has integrated HBV screening into its standard prenatal package, ensuring that infants born to HBV-positive mothers receive timely vaccinations and immunoglobulin treatment at birth.
The WHO is currently working closely with Danish authorities to advance the triple elimination validation process. Reaching this next stage would solidify Denmark’s position as a global leader in preventative medicine and neonatal protection.
Global Context and the Path Forward
Denmark now joins a select group of 22 other countries and territories that have been validated by the WHO for the elimination of mother-to-child transmission of one or more of these viruses. This list includes diverse nations such as Cuba—the first to be validated in 2015—as well as Thailand, Malaysia, Sri Lanka, Botswana, and several Caribbean nations including Antigua and Barbuda, Belize, and Jamaica. Other European nations on the list include Armenia, Belarus, and the Republic of Moldova.
The inclusion of Denmark is particularly significant for the European region, as it demonstrates that high-income countries with complex migration patterns and urbanized populations can still achieve the "gold standard" of elimination through meticulous planning and resource allocation.
The implications of Denmark’s certification extend beyond its borders. As a model of excellence, the Danish experience provides a motivator for other EU member states and global partners. The country’s ability to maintain high laboratory capacity, robust surveillance, and a dedicated workforce of midwives and specialists offers a roadmap for nations seeking to strengthen their own EMTCT programs.
Conclusion: A Model for the Future
The WHO certification of Denmark is more than a formal recognition; it is a validation of a social contract that prioritizes the health of the next generation. By ensuring that the transmission of HIV and syphilis from mother to child is a thing of the past, Denmark has protected the lives and futures of thousands of children.
As the global community works toward the United Nations Sustainable Development Goals, specifically Goal 3.3 which aims to end the epidemics of AIDS and other communicable diseases by 2030, Denmark’s achievement serves as a beacon of possibility. The focus now shifts to maintaining these gains and completing the journey toward triple elimination with the inclusion of hepatitis B. For the international health community, Denmark has proven that with the right combination of science, policy, and human rights, the goal of an AIDS-free and syphilis-free generation is entirely within reach.